Clinical Trial Update: Teplizumab in Pediatric Stage 2 Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for teplizumab in pediatric Stage 2 Type 1 diabetes; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• TZIELD (TEPLIZUMAB-MZWV)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: ACTIVE_NOT_RECRUITING